🎥 @mhairicopland.bsky.social of @uofglasgow.bsky.social comments on the challenges of co-targeting in CML, highlighting the need to balance efficacy with minimizing additional side effects, particularly in patients who have achieved remission:

👉 buff.ly/eSCKsvx 👈

#SOHO2025 #CMLsm #Leusm #HemOnc

At #IPIG2025, we spoke to Pat Garcia-Gonzalez, co-founder & CEO of @themaxfoundation.org‬, to learn about the projects of this important organization.🌍🩸

Find out how the Max Foundation is revolutionizing treatment access & accelerating health equity:

🎥 buff.ly/gm7hrSt

#CMLsm #Leusm

Brochure in red and white with gray that advertises the International John Goldman Research Award from the European School of Haematology. It states there is a call for 2025 applications and there are 2 weeks left before the deadline. It displays a round emblem related to the award name.

Do you have a research project about #MRD in #CML + related diseases? The team at ESH is offering a research award of €80k! The deadline to apply is soon -🚨May 15th. More info: www.esh.org/john-goldman...
#CMLsm

We recently had the pleasure of speaking with Daniela Žáčková to hear about TKI dose reduction before treatment-free remission in patients with CML.

Want to learn more?

Watch the interview here:
🎥 buff.ly/QEvhmwm

#CMLsm #Leusm #HemOnc #ESHCMLMPN2025 #MedSky #BloodSky #HemeSky

Don't forget to check our exclusive virtual coverage of the recent ESH CML/MPN meeting if you want to hear the latest in CML, MPN, & CMML!🩸

Click here to explore:

🎥 buff.ly/ENlF9MF

#CMLsm #MPNsm #Leusm #ESHCMLMPN2025 #Hematology #MedSky #BloodSky #HemeSky

Did you miss out on our post-ASH highlights webinars in which leading experts presented key abstracts from #ASH24?💻🩸

Not to worry! You can now catch up on the exclusive presentations & discussions here:
👉 buff.ly/4hMI6Nr 👈

#CLLsm #CMLsm #LYMsm #Leusm #MMSM #MDSsm #MPNsm #AMLsm #CTSM #HemOnc

🎥 At #ASH24, Elisabetta Abruzzese commented on the potential value of transitioning from high-potency to low-potency inhibitors in patients with chronic myeloid leukemia.

Watch here:

👉 https://buff.ly/3ZY0k7P 👈

#CMLsm #Leusm #MedSky #BloodSky #HemeSky #HemeOnc @ash-hematology.bsky.social